BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9550365)

  • 41. Neural tube defects and deletions of 22q11.
    Nickel RE; Magenis RE
    Am J Med Genet; 1996 Dec; 66(1):25-7. PubMed ID: 8957506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of chromosomal abnormalities and 22q11.2 deletion in conotruncal and non-conotruncal antenatally diagnosed congenital heart diseases in a Chinese population.
    Kong CW; Cheng YKY; To WWK; Leung TY
    Hong Kong Med J; 2019 Feb; 25(1):6-12. PubMed ID: 30655461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities.
    Yakut T; Kilic SS; Cil E; Yapici E; Egeli U
    Pediatr Surg Int; 2006 Apr; 22(4):380-3. PubMed ID: 16463032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microdeletion and microduplication 22q11.2 screening in 295 patients with clinical features of DiGeorge/Velocardiofacial syndrome.
    Brunet A; Gabau E; Perich RM; Valdesoiro L; Brun C; Caballín MR; Guitart M
    Am J Med Genet A; 2006 Nov; 140(22):2426-32. PubMed ID: 17041934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tricuspid atresia and 22q11 deletion.
    Marino B; Digilio MC; Novelli G; Giannotti A; Dallapiccola B
    Am J Med Genet; 1997 Oct; 72(1):40-2. PubMed ID: 9295072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome.
    Amati F; Conti E; Novelli A; Bengala M; Diglio MC; Marino B; Giannotti A; Gabrielli O; Novelli G; Dallapiccola B
    Eur J Hum Genet; 1999 Dec; 7(8):903-9. PubMed ID: 10602366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 22q11.2 deletion in patients with conotruncal heart defect and del22q syndrome phenotype.
    Belangero SI; Bellucco FT; Kulikowski LD; Christofolini DM; Cernach MC; Melaragno MI
    Arq Bras Cardiol; 2009 Apr; 92(4):307-11. PubMed ID: 19565140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch.
    Rauch A; Hofbeck M; Leipold G; Klinge J; Trautmann U; Kirsch M; Singer H; Pfeiffer RA
    Am J Med Genet; 1998 Jul; 78(4):322-31. PubMed ID: 9714433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening of patients at risk for 22q11 deletion.
    Barisić I; Morozin Pohovski L; Petković I; Cvetko Z; Stipancić G; Bagatin M
    Coll Antropol; 2008 Mar; 32(1):165-9. PubMed ID: 18494202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosomal abnormalities among children born with conotruncal cardiac defects.
    Lammer EJ; Chak JS; Iovannisci DM; Schultz K; Osoegawa K; Yang W; Carmichael SL; Shaw GM
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):30-5. PubMed ID: 19067405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromosome 22q11 deletions in patients with conotruncal heart defects.
    Khositseth A; Tocharoentanaphol C; Khowsathit P; Ruangdaraganon N
    Pediatr Cardiol; 2005; 26(5):570-3. PubMed ID: 16132309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2.
    Matsuoka R; Takao A; Kimura M; Imamura S; Kondo C; Joh-o K; Ikeda K; Nishibatake M; Ando M; Momma K
    Am J Med Genet; 1994 Nov; 53(3):285-9. PubMed ID: 7856665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congenital cardiac defects with 22q11 deletion.
    Giray O; Ulgenalp A; Bora E; Sağin Saylam G; Unal N; Meşe T; Hüdaoğlu S; Erçal D
    Turk J Pediatr; 2003; 45(3):217-20. PubMed ID: 14696799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chromosome 22 microdeletion by F.I.S.H. in isolated congenital heart disease.
    Gawde H; Patel ZM; Khatkhatey MI; D'Souza A; Babu S; Adhia R; Kerkar P
    Indian J Pediatr; 2006 Oct; 73(10):885-8. PubMed ID: 17090899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microdeletion 22q11 and oesophageal atresia.
    Digilio MC; Marino B; Bagolan P; Giannotti A; Dallapiccola B
    J Med Genet; 1999 Feb; 36(2):137-9. PubMed ID: 10051013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease.
    Huber J; Peres VC; de Castro AL; dos Santos TJ; da Fontoura Beltrão L; de Baumont AC; Cossio SL; Dalberto TP; Riegel M; Cañedo AD; Schaan BD; Pellanda LC
    Pediatr Cardiol; 2014 Dec; 35(8):1356-62. PubMed ID: 24880467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Der(22) syndrome and velo-cardio-facial syndrome/DiGeorge syndrome share a 1.5-Mb region of overlap on chromosome 22q11.
    Funke B; Edelmann L; McCain N; Pandita RK; Ferreira J; Merscher S; Zohouri M; Cannizzaro L; Shanske A; Morrow BE
    Am J Hum Genet; 1999 Mar; 64(3):747-58. PubMed ID: 10053009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet parameters in children with chromosome 22q11 deletion and conotruncal heart defects.
    Anilkumar A; Vasudevan DM; Kappanayil M; Sundaram KR; Krishna Kumar R; Nampoothiri S
    Congenit Heart Dis; 2018 May; 13(3):483-487. PubMed ID: 29508558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal diagnosis and molecular cytogenetic characterization of chromosome 22q11.2 deletion syndrome associated with congenital heart defects.
    Kuo YL; Chen CP; Wang LK; Ko TM; Chang TY; Chern SR; Wu PS; Chen YT; Chang SY
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):248-51. PubMed ID: 25017279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.